Skip Navigation LinksHome > November 2009 - Volume 16 - Issue 6 > Connective Tissue Disease and the Lung
Clinical Pulmonary Medicine:
doi: 10.1097/CPM.0b013e3181be0eb9

Connective Tissue Disease and the Lung

Goh, Nicole S. L. MD



The article that appeared on page 309 of the November 2009 issue of the journal was listed as a Review article. The correct article type for this article is Interstitial, Inflammatory, and Occupational Lung Disease.

The journal apologizes for this error.

Clinical Pulmonary Medicine. 17(2):109, March 2010.

Collapse Box


Interstitial lung disease in connective tissue disorders is common and causes significant morbidity and mortality. However, the clinical course is highly variable, ranging from indolent to rapidly progressive. Hence, optimal prognostic evaluation is crucial to identify patients at greater risk who should be treated, while avoiding toxicities in those who can be best observed. A pivotal part of this assessment is the quantification of baseline severity and longitudinal disease behavior. In systemic sclerosis-interstitial lung disease, a simple staging system, combining the use of high-resolution computed tomography disease extent and forced vital capacity levels, readily classifies patients into having either mild or extensive disease. The combination of high-resolution computed tomography and forced vital capacity levels provide more powerful prognostic significance than either measurement alone.

© 2009 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.